Molecular signature of human amniotic fluid stem cells during fetal development

Current Stem Cell Research and Therapy

Volumn 8, Issue 1, 2013, Pages 73-81

  Moschidou, Dafni ^a   Drews, Katharina ^b   Eddaoudi, Ayad ^c   Adjaye, James ^b,d   de Coppi, Paolo ^c   Guillot, Pascale V ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Amniotic fluid; Amniotic fluid stem cells; c KIT; Gene expression; Human embryonic stem cells; Stem cells; Transcriptome

Indexed keywords

TRANSCRIPTOME;

AMNION FLUID; AMNIOTIC FLUID STEM CELL; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL SHAPE; CELL SIZE; COMPARATIVE STUDY; CONTROLLED STUDY; ECHOGRAPHY; EMBRYO DEVELOPMENT; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CHROMOSOME; MICROSCOPY; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; REFRACTION INDEX; SECOND TRIMESTER PREGNANCY; SPERMATOGENESIS; STEM CELL; X CHROMOSOME; Y CHROMOSOME;

ADULT; AMNIOTIC FLUID; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FETAL DEVELOPMENT; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; STEM CELLS;

EID: 84879774872     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X11308010009     Document Type: Article

References (33)

1. Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschlager M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 2003; 18(7): 1489-93.
2. Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004; 19(6): 1450-6.
3. Ryan JM, Pettit AR, Guillot PV, Chan JK, Fisk NM. Unravelling the Pluripotency Paradox in Fetal and Placental Mesenchymal Stem Cells: Oct-4 Expression and the Case of the Emperor's New Clothes. Stem Cell Rev 2011; [Epub ahead of print].
4. De Coppi P, Bartsch G, Jr., Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25(1): 100-6.
5. Cananzi M, Atala A, De Coppi P. Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online 2009; 18(Suppl 1): 17-27.
6. Ditadi A, de Coppi P, Picone O, et al. Human and murine amniotic fluid c-Kit+Lin-cells display hematopoietic activity. Blood 2009; 113(17): 3953-60.
7. Kaviani A, Guleserian K, Perry TE, Jennings RW, Ziegler MM, Fauza DO. Fetal tissue engineering from amniotic fluid. J Am Coll Surg 2003; 196(4): 592-7.
8. Tsai MS, Hwang SM, Tsai YL, Cheng FC, Lee JL, Chang YJ. Clonal amniotic fluid-derived stem cells express characterisitcs of both mesenchymal and neural stem cells. BOR. 2005 Jun.
9. Perin L, Giuliani S, Jin D, et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif 2007; 40(6): 936-48.
10. Siegel N, Rosner M, Unbekandt M, et al. Contribution of human amnitoic fluid stem cells to renal tissue formation depends on mTOR. Hum Mol Genet 2010; 19(17): 3320-31.
11. Rosner M, Mikula M, Preitschopf A, Feichtinger M, Schipany K, Hengstschlager M. Neurogenic differentiation of amniotic fluid stem cells. Amino Acids 2012; 42(5): 1591-6.
12. Bollini S, Pozzobon M, Nobles M, et al. In vitro and In vivo Cardiomyogenic Differentiation of Amniotic Fluid Stem Cells. Stem Cell Rev 2011; 7(2): 364-80.
13. Piccoli M, Franzin C, Bertin E, et al. Amniotic Fluid Stem Cells Restore the Muscle Cell Niche in a HSA-Cre, Smn(F7/F7) Mouse Model 2012; 30(8): 1675-84.
14. Moschidou D, Mukherjee S, Blundell MP, et al. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther 2012; 20(10): 1953-67.
15. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4): 663-76.
16. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318(5858): 1917-20.
17. Mukherjee S, Thrasher A. iPSCs: Unstable Origins? Mol Ther 2011; 19: 1188-90.
18. Galende E, Karakikes I, Edelmann L, et al. Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogram 2010; 12(2): 117-25
19. Li C, Zhou J, Shi G, et al. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet 2009; 18(22): 4340-9.
20. Ye L, Chang JC, Lin C, Sun X, Yu J, Kan YW. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci USA. 2009; 106(24): 9826-30.
21. Wolfrum K, Wang Y, Prigione A, Sperling K, Lehrach H, Adjaye J. The LARGE principle of cellular reprogramming: lost, acquired and retained gene expression in foreskin and amniotic fluid-derived human iPS cells. PLoS One 2010; 5(10): e13703.
22. Angel M, Yanik MF. Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One 2010; 5(7): e11756.
23. Drews K, Tavernier G, Demeester J, et al. The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts. Biomaterial 2012; 33(16): 4056-68.
24. Guillot PV, De Bari C, Dell'Accio F, Kurata H, Polak J, Fisk NM. Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation 2008; 76(9): 946-57.
25. Guillot PV, Gotherstrom C, Chan J, Kurata H, Fisk NM. Human first trimester fetal mesenchymal stem cells (MSC) express pluripotency markers, grow faster and have longer telomeres compared to adult MSC. Stem cells 2007; 25(3): 646-54.
26. Guillot PV, O'Donoghue K, Fisk NM. Fetal stem cells: betwixt and between. Seminars Reprod Med 2006; 24(5): 340-7.
27. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4(1): 44-57.
28. Di Stefano B, Prigione A, Broccoli V. Efficient Genetic Reprogramming of Unmodified Somatic Neural Progenitors Uncovers the Essential Requirement of Oct4 and Klf4. Stem Cell Dev 2009; 18: 707-15
29. Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4(6): 472-6.
30. Sterneckert J, Hoing S, Scholer HR. Oct4 and more: the reprogramming expressway. Stem Cells 2012; 30(1): 15-21.
31. Kim JB, Greber B, Arauzo-Bravo MJ, et al. Direct reprogramming of human neural stem cells by oct4. Nature 2009; 461(7264): 649-3.
32. Kim JB, Sebastiano V, Wu G, et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009; 136(3): 411-19.
33. Shaw SW, David AL, De Coppi P. Clinical applications of prenatal and postnatal therapy using stem cells retrieved from amniotic fluid. Curr Opin Obstet Gynecol 2011; 23(2): 109-16.